E A Chrischilles
Overview
Explore the profile of E A Chrischilles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gagne J, Han X, Hennessy S, Leonard C, Chrischilles E, Carnahan R, et al.
Clin Pharmacol Ther
. 2016 Jul;
100(5):558-564.
PMID: 27416001
The US Food and Drug Administration's Sentinel system has developed the capability to conduct active safety surveillance of marketed medical products in a large network of electronic healthcare databases. We...
2.
Carnahan R, Lund B, Perry P, Chrischilles E
Acta Psychiatr Scand
. 2006 Jan;
113(2):135-41.
PMID: 16423165
Objective: To determine whether atypical antipsychotic polytherapy is a risk factor for drug treatment for extrapyramidal side-effects (anti-EPS drugs) and whether the risk is attributable to antipsychotic dose. Method: We...
3.
Melton 3rd L, Chrischilles E, Cooper C, Lane A, Riggs B
J Bone Miner Res
. 2005 Jun;
20(5):886-92.
PMID: 15931736
No abstract available.
4.
Chrischilles E, Dasbach E, Rubenstein L, Cook J, Tabor H, Black D
Osteoporos Int
. 2001 Oct;
12(8):654-60.
PMID: 11580079
The Vertebral Fracture Arm (VFA) of the Fracture Intervention Trial (FIT) study demonstrated that alendronate reduced the incidence of spine, forearm and hip fractures in women with low bone mass...
5.
Rubenstein L, DeLeo A, Chrischilles E
Pharmacoeconomics
. 2001 Sep;
19(7):729-52.
PMID: 11548910
The progressive disability of Parkinson's disease results in substantial burdens for patients, their families and society in terms of increased health resource use, poorer quality of life, caregiver burden, disrupted...
6.
Armstrong E, Chrischilles E
Arch Intern Med
. 2000 Oct;
160(18):2713-4.
PMID: 11025780
No abstract available.
7.
Chrischilles E, SCHOLZ D
Clin Perform Qual Health Care
. 2000 Apr;
7(2):107-11.
PMID: 10747563
This paper explains practical approaches for collecting inpatient cost data for cost-of-illness and cost-effectiveness analyses. The economic definition of cost of an item is the value of the resources that...
8.
Hoerger T, Bala M, Rowland C, Greer M, Chrischilles E, Holloway R
Pharmacoeconomics
. 1999 May;
14(5):541-57.
PMID: 10344917
Objective: Pramipexole was recently approved in the US for treatment of the symptoms of idiopathic Parkinson's disease (PD). Although pramipexole has been found to be safe and efficacious when compared...
9.
Kuehl A, Chrischilles E, Sorofman B
J Am Pharm Assoc (Wash)
. 1998 Jul;
38(3):317-24.
PMID: 9654862
Objectives: A system for exchanging patient information among hospital, long-term-care (LTC), and ambulatory care pharmacies is described, and the influence of that system on pharmacist interventions is reported. Methods: Study...
10.
Chrischilles E, Rubenstein L, Voelker M, Wallace R, Rodnitzky R
Mov Disord
. 1998 Jun;
13(3):406-13.
PMID: 9613729
Parkinson's disease (PD) is likely to have a substantial impact on an individual's health-related quality of life (HRQL), health-related resource use, and productivity. Data about the health burdens of PD...